PROSTAGLANDINS & OTHER LIPID MEDIATORS

PROSTAGLANDINS & OTHER LIPID MEDIATORS

PROSTAG OTH LIPID M
影响因子:2.5
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:Elsevier Inc.
发刊时间:1998
发刊频率:Monthly
收录数据库:SCIE/Scopus收录
ISSN:1098-8823

期刊介绍

Prostaglandins & Other Lipid Mediators is the original and foremost journal dealing with prostaglandins and related lipid mediator substances. It includes basic and clinical studies related to the pharmacology, physiology, pathology and biochemistry of lipid mediators.Prostaglandins & Other Lipid Mediators invites reports of original research, mini-reviews, reviews, and methods articles in the basic and clinical aspects of all areas of lipid mediator research: cell biology, developmental biology, genetics, molecular biology, chemistry, biochemistry, physiology, pharmacology, endocrinology, biology, the medical sciences, and epidemiology.Prostaglandins & Other Lipid Mediators also accepts proposals for special issue topics. The Editors will make every effort to advise authors of the decision on the submitted manuscript within 3-4 weeks of receipt.
前列腺素和其他脂质介质是原始的和最重要的杂志处理前列腺素和相关的脂质介质物质。前列腺素和其他脂质介质邀请在脂质介质研究的所有领域的基础和临床方面的原始研究报告、小型综述、综述和方法文章:细胞生物学、发育生物学、遗传学、分子生物学、化学、生物化学、生理学、药理学、内分泌学、生物学、医学科学和流行病学。2前列腺素和其它脂质介体也接受特刊主题的建议。编辑将尽一切努力在收到稿件后3-4周内通知作者。
年发文量 88
国人发稿量 10.81
国人发文占比 0.12%
自引率 -
平均录取率0
平均审稿周期 平均2月
版面费 US$3170
偏重研究方向 生物-生化与分子生物学
期刊官网 http://www.elsevier.com/wps/find/journaldescription.cws_home/525019/description#description
投稿链接 https://www.editorialmanager.com/POLM

期刊高被引文献

The role of n-3 PUFA-derived fatty acid derivatives and their oxygenated metabolites in the modulation of inflammation.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106351
Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106338
Prostaglandin D2-ethanolamide induces skin cancer apoptosis by suppressing the activity of cellular antioxidants.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.03.001
Oxysterols as lipid mediators: Their biosynthetic genes, enzymes and metabolites
来源期刊:Prostaglandins & Other Lipid MediatorsDOI:10.1016/j.prostaglandins.2019.106381
Mammary cancer risk and serum lipid profile of rats supplemented with pomegranate seed oil and bitter melon extract.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.03.005
Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activity.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2018.12.003
Lysophosphatidic acid: Its role in bone cell biology and potential for use in bone regeneration.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106335
A strategy for validating concentrations of oxylipin standards for external calibration.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.02.006
Formation of trans-epoxy fatty acids correlates with formation of isoprostanes and could serve as biomarker of oxidative stress.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.04.004
Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106363
A JOURNEY OF CELECOXIB FROM PAIN TO CANCER.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106379
Effects of nonsteroidal anti-inflammatory drugs on the expression of arachidonic acid-metabolizing Cyp450 genes in mouse hearts, kidneys and livers.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.02.003
Cytochrome P450-Derived Eicosanoids and Inflammation in Liver Diseases.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106400
Lipid Mediators of Inflammation and Resolution in Individuals with Tuberculosis and Tuberculosis-Diabetes.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106398
PGE2 in fibrosis and cancer: Insights into fibroblast activation.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106339
Physiological and pathological levels of prostaglandin E2 in renal parenchyma and neoplastic renal tissue.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.02.004
Respective contribution of cytosolic phospholipase A2α and secreted phospholipase A2 IIA to inflammation and eicosanoid production in arthritis.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106340
BML-111, a lipoxin receptor agonist, protects against acute injury via regulating the renin angiotensin-aldosterone system.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2018.11.001
Parasitic load determination by differential expression of 5-Lipoxygenase and PGE2 Synthases in Visceral Leishmaniasis.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106390
The role of sphingosine 1-phosphate receptors on retinal pigment epithelial cells barrier function and angiogenic effects.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106365
Role of cytochrome P450-derived, polyunsaturated fatty acid mediators in diabetes and the metabolic syndrome.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106407
Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106348
Eicosanoids derived from cytochrome P450 pathway of arachidonic acid and inflammatory shock.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106377
VIP modulates the ALX/FPR2 receptor axis toward inflammation resolution in a mouse model of bacterial keratitis.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2018.12.001
Dietary omega-3 PUFA improved tubular function after ischemia induced acute kidney injury in mice but did not attenuate impairment of renal function.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106386
Flax seed oil reduced tumor growth, modulated immune responses and decreased HPV E6 and E7 oncoprotein expression in a murine model of ectopic cervical cancer.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.04.002
THE EFFECT OF THE EP3 ANTAGONIST DG-041 ON MALE MICE WITH DIET-INDUCED OBESITY.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106353
Neutral sphingomyelinase increases and delocalizes in the absence of Toll-Like Receptor 4: A new insight for MPTP neurotoxicity.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.03.004
Prostaglandin E2, a postulated mediator of neurovascular coupling, at low concentrations dilates whereas at higher concentrations constricts human cerebral parenchymal arterioles.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106389
Oxidative pathways of arachidonic acid as targets for regulation of platelet activation.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106382
Omega-3 fatty acids and docosahexaenoic acid oxymetabolites modulate the inflammatory response of equine recombinant interleukin1β-stimulated equine synoviocytes.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.02.007
Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106401
5-oxo-ETE activates migration of H295R adrenocortical cells via MAPK and PKC pathways.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106346
Increased pain and inflammatory sensitivity in growth hormone-releasing hormone (GHRH) knockout mice.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106362
Urinary prostaglandin D2 and E2 metabolites associate with abdominal obesity, glucose metabolism, and triglycerides in obese subjects.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106361
Formyl-peptide receptor 2 suppresses proliferation, migration and invasion in human extravillous trophoblastic cells.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106342
Prostaglandin E2 and an EP4 receptor agonist inhibit LPS-Induced monocyte chemotactic protein 5 production and secretion in mouse cardiac fibroblasts via Akt and NF-κB signaling.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106349
Lipoxin A4 inhibited the activation of hepatic stellate cells -T6 cells by modulating profibrotic cytokines and NF-κB signaling pathway.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106380
Detoxification and activating blood circulation decoction reduces restenosis involving the TLR4/NF-κB pathway after balloon injury.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2018.11.002
Do arachidonic acid metabolites affect apoptosis in bovine endometrial cells with silenced PPAR genes?
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106336
Regulation of nicotinic acetylcholine receptor α3 subtype in adipose tissue dysfunction.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.04.001
Seasonal expressions of COX-1, COX-2 and EP4 in the uteri of the wild Daurian ground squirrels (Spermophilus dauricus).
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106343
Interaction between PGI2 and ET-1 pathways in vascular smooth muscle from Group-III pulmonary hypertension patients.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106388
Role of sphingolipids in the pathogenesis of intrahepatic cholestasis.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106399
Metabolic studies of synaptamide in an immortalized dopaminergic cell line.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.02.002
Liquid chromatography-coupled mass spectrometry analysis of glutathione conjugates of oxygenated polyunsaturated fatty acids.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106350
The role of lipoxin in regulating tumor immune microenvironments.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106341
Enhancement by HSP90 inhibitor of PGD2-stimulated HSP27 induction in osteoblasts: Suppression of SAPK/JNK and p38 MAP kinase.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.03.002
A combination of LCPUFAs regulates the expression of miRNA-146a-5p in a murine asthma model and human alveolar cells.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106378
Quantifying 1-deoxydihydroceramides and 1-deoxyceramides in mouse nervous system tissue.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.02.005

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
82.95%13.37%--

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q3区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
BIOCHEMISTRY & MOLECULAR BIOLOGY
Q3

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
生物学3区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学
4区
CELL BIOLOGY 细胞生物学
4区
2023年12月升级版
生物学3区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学
4区
CELL BIOLOGY 细胞生物学
4区
2022年12月旧的升级版
生物学3区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学
3区
CELL BIOLOGY 细胞生物学
4区